This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2019 Mar;184(5):884-886.

doi: 10.1111/bjh.15766.

Corrigendum

No authors listed

PMID: 30775794
DOI: 10.1111/bjh.15766

Published Erratum

Corrigendum

No authors listed. Br J Haematol. 2019 Mar.

. 2019 Mar;184(5):884-886.

doi: 10.1111/bjh.15766.

PMID: 30775794
DOI: 10.1111/bjh.15766

No abstract available

PubMed Disclaimer

Erratum for

The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.
Dasmahapatra G, Patel H, Dent P, Fisher RI, Friedberg J, Grant S. Dasmahapatra G, et al. Br J Haematol. 2013 Apr;161(1):43-56. doi: 10.1111/bjh.12206. Epub 2013 Jan 30. Br J Haematol. 2013. PMID: 23360303 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley